Johnson & Johnson/Centocor - IPNY https://ipny.com Thu, 02 Feb 2023 01:50:27 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.2 https://ipny.com/wp-content/uploads/2021/01/cropped-favicon-32-32x32.png Johnson & Johnson/Centocor - IPNY https://ipny.com 32 32 From the heart. https://ipny.com/work/johnson-johnson-centocor-from-the-heart/?utm_source=rss&utm_medium=rss&utm_campaign=johnson-johnson-centocor-from-the-heart Sat, 03 Jul 2021 16:00:50 +0000 https://2021website.interplanetaryhq.com/?post_type=ohio_portfolio&p=154195
Johnson & Johnson/Centocor

From the heart.

Speaking to chemotherapy patients requires empathy, honesty and above all, authenticity. So when the Ortho-Biotech division of Johnson &Johnson asked us to launch Procrit, a drug that helps chemotherapy patients overcome the extreme fatigue from chemo-induced anemia, the challenge was to create a compelling voice that would motivate the target to have a the right conversation with their oncologists.

“From the Heart” was revolutionary. It was one of the first TV commercials to use the voice and perspective of a cancer patient, not a physician. Shot by legendary director Leslie Dektor, it was produced with the kind of production values that at the time were reserved only for mainstream advertising.

Results: A classic that has influenced hundreds of DTC campaigns, this launch work helped build Procrit into Johnson & Johnson’s largest-selling prescription drug, winning the J&J Bellringer Award for best campaign.

The post From the heart. first appeared on IPNY.

]]>
Launching the first biologic drug for RA treatment. https://ipny.com/work/johnson-johnson-centocor-launching-the-first-biologic-drug-for-ra-treatment/?utm_source=rss&utm_medium=rss&utm_campaign=johnson-johnson-centocor-launching-the-first-biologic-drug-for-ra-treatment Fri, 02 Jul 2021 16:00:47 +0000 https://2021website.interplanetaryhq.com/?post_type=ohio_portfolio&p=154190
Johnson & Johnson/Centocor

Launching the first biologic drug
for RA treatment.

The launch of Centocor/Johnson & Johnson’s Remicade was big news. A first-of-its-kind biologic drug for the treatment of Rheumatoid Arthritis, Remicade treated the underlying cause of this autoimmune condition and made real remission possible.

In developing Remicade’s first DTC campaign for RA, we needed to find a unique way to connect with patients everywhere. Our campaign, with compelling insights gleaned from ethnographic research, reflected a deep understanding of the progressive nature of RA, and how patients viewed the timeline of this disease as a constant series of tradeoffs.

Results: The campaign was so successful that by the end of the brand’s launch year, Remicade had won the J&J’s coveted Bellringer award for sales and creative excellence.

The post Launching the first biologic drug for RA treatment. first appeared on IPNY.

]]>